Further, C3 and other complement components were significantly increased by metronomic CPA treatment in both tumor models (Additional file 2: Figure S7) and likely contribute to the observed innate immune activation and clearance of dying tumor cells [86]. The gene discussed is C3; the disease is neoplasm.